Psychedelic Therapy with Roland Griffiths, PhD

Speaking of Psychology

Kim Mills

Health & Fitness, Life Sciences, Science, Mental Health

4.3 • 781 Ratings

🗓️ 15 July 2020

⏱️ 45 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Psilocybin, LSD and other psychedelic drugs were once considered promising treatments for depression, anxiety and other mental health ailments. Now, after a decades-long lull, researchers are once again looking into the therapeutic potential of these drugs. Roland Griffiths, PhD, a professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, discusses new research on using psychedelics to treat depression, PTSD, and even alcohol and tobacco dependence. Links: Usona Institute Compass Pathways Join us online August 6-8 for APA 2020 Virtual. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	This episode is brought to you by Shopify.
0:03.0	Looking to start a side hustle or become your own boss, do it with Shopify.
0:06.9	Whether you're selling succulents or stilettos,
0:09.3	Shopify has the industry leading tools to help you create, control and grow your own business.
0:13.9	So get serious about selling and get Shopify today.
0:16.9	Sign up for a £1 per month trial period at Shopify.com.com slash special offer, all lowercase.
0:23.1	That's Shopify.comaek slash special offer.
0:29.4	Turn on, tune in, drop out.
0:33.5	This phrase was made famous by Harvard psychologist Timothy Leary, who in the 1960s was studying whether psychedelic drugs, particularly psilocybin and LSD, could have therapeutic uses.
0:45.5	For a lot of reasons, including that he took the drugs along with his student subjects, LERY was fired from Harvard, and LSD, psilocybin, and other hallucinogenic drugs were deemed illegal by the Food and Drug Administration.
0:59.3	Fast forward to 2020. Psychological research with hallucinogenic drugs is a legitimate field of study again,
1:05.9	with the FDA allowing a handful of medical research organizations to conduct what's called breakthrough therapy with psychedelics.
1:13.7	Researchers are looking at whether these drugs can be used to treat depression, anorexia, PTSD, and even alcohol and tobacco dependence.
1:22.3	In June, advocates in Oregon announced they had gathered enough signatures to put an initiative on the state's
1:27.9	November ballot that would legalize psilocybin-assisted therapy. Meanwhile, Washington, D.C. voters
1:34.2	are likely to consider a psilocybin decriminalization measure this fall, following the examples
1:39.8	of cities including Denver and Oakland and Santa Cruz, California, which have recently passed
1:45.2	similar measures. So what's different about today's research using psychedelics? How do drugs
1:51.8	that have long been considered taboo and polite society become tools for treating a growing
1:56.5	number of mental health issues? We will be delving into these and other questions today here on
2:01.7	Speaking of Psychology, the flagship podcast of the American Psychological Association, that
2:07.0	explores the connections between psychological science and everyday life. I'm Kim Mills.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Kim Mills, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Kim Mills and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.